These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 6300166

  • 1. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.
    Pang S, Levine LS, Stoner E, Opitz JM, Pollack MS, Dupont B, New MI.
    J Clin Endocrinol Metab; 1983 Apr; 56(4):808-18. PubMed ID: 6300166
    [Abstract] [Full Text] [Related]

  • 2. Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.
    Chang YT, Kulin HE, Garibaldi L, Suriano MJ, Bracki K, Pang S.
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1251-7. PubMed ID: 8077318
    [Abstract] [Full Text] [Related]

  • 3. Male pseudohermaphroditism due to nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency: gender role change and absence of gynecomastia at puberty.
    Mendonca BB, Bloise W, Arnhold IJ, Batista MC, Toledo SP, Drummond MC, Nicolau W, Mattar E.
    J Steroid Biochem; 1987 Dec; 28(6):669-75. PubMed ID: 2826919
    [Abstract] [Full Text] [Related]

  • 4. Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency.
    Rhéaume E, Sanchez R, Simard J, Chang YT, Wang J, Pang S, Labrie F.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1012-8. PubMed ID: 7962268
    [Abstract] [Full Text] [Related]

  • 5. Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.
    Sakkal-Alkaddour H, Zhang L, Yang X, Chang YT, Kappy M, Slover RS, Jorgensen V, Pang S.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3961-5. PubMed ID: 8923844
    [Abstract] [Full Text] [Related]

  • 6. New studies of the 11 beta-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia.
    Levine LS, Rauh W, Gottesdiener K, Chow D, Gunczler P, Rapaport R, Pang S, Schneider B, New MI.
    J Clin Endocrinol Metab; 1980 Feb; 50(2):258-63. PubMed ID: 6243663
    [Abstract] [Full Text] [Related]

  • 7. Zona glomerulosa function after life-long suppression in two siblings with the hypertensive virilizing form of congenital adrenal hyperplasia.
    Rodríguez Portales JA, Arteaga E, López Moreno JM, Biglieri EG.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):349-54. PubMed ID: 3276723
    [Abstract] [Full Text] [Related]

  • 8. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.
    Lutfallah C, Wang W, Mason JI, Chang YT, Haider A, Rich B, Castro-Magana M, Copeland KC, David R, Pang S.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2611-22. PubMed ID: 12050224
    [Abstract] [Full Text] [Related]

  • 9. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
    Zhang L, Sakkal-Alkaddour H, Chang YT, Yang X, Pang S.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):291-5. PubMed ID: 8550766
    [Abstract] [Full Text] [Related]

  • 10. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB, Ehrmann DA, Brigell DF, Rosenfield RL.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [Abstract] [Full Text] [Related]

  • 11. Mild adrenal 3 beta-hydroxysteroid dehydrogenase deficiency with hyperaldosteronism.
    Hashimoto K, Makino S, Takao T, Sugawara M, Suemaru S, Ota Z.
    Endocrinol Jpn; 1988 Oct; 35(5):675-83. PubMed ID: 3220046
    [Abstract] [Full Text] [Related]

  • 12. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
    Pang SY, Lerner AJ, Stoner E, Levine LS, Oberfield SE, Engel I, New MI.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
    [Abstract] [Full Text] [Related]

  • 13. Normal ovarian function in a mild form of late-onset 3 beta-hydroxysteroid dehydrogenase deficiency.
    Medina M, Herrera J, Flores M, Martin O, Bermúdez JA, Zárate A.
    Fertil Steril; 1986 Dec; 46(6):1021-5. PubMed ID: 3023147
    [Abstract] [Full Text] [Related]

  • 14. A new inherited variant of the 3 beta-hydroxysteroid dehydrogenase-isomerase deficiency syndrome: evidence for the existence of two isoenzymes.
    Cravioto MD, Ulloa-Aguirre A, Bermudez JA, Herrera J, Lisker R, Mendez JP, Perez-Palacios G.
    J Clin Endocrinol Metab; 1986 Aug; 63(2):360-7. PubMed ID: 3088022
    [Abstract] [Full Text] [Related]

  • 15. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.
    Lucky AW, Rosenfield RL, McGuire J, Rudy S, Helke J.
    J Clin Endocrinol Metab; 1986 May; 62(5):840-8. PubMed ID: 3007557
    [Abstract] [Full Text] [Related]

  • 16. Molecular basis of congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency.
    Simard J, Rhéaume E, Sanchez R, Laflamme N, de Launoit Y, Luu-The V, van Seters AP, Gordon RD, Bettendorf M, Heinrich U.
    Mol Endocrinol; 1993 May; 7(5):716-28. PubMed ID: 8316254
    [Abstract] [Full Text] [Related]

  • 17. Plasma 3 beta-hydroxy-delta 5-steroids in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Young J, Couzinet B, Pholsena M, Nahoul K, Labrie F, Schaison G.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):299-304. PubMed ID: 8106615
    [Abstract] [Full Text] [Related]

  • 18. Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency.
    Sanchez R, Rhéaume E, Laflamme N, Rosenfield RL, Labrie F, Simard J.
    J Clin Endocrinol Metab; 1994 Mar; 78(3):561-7. PubMed ID: 8126127
    [Abstract] [Full Text] [Related]

  • 19. Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity.
    Chang YT, Zhang L, Alkaddour HS, Mason JI, Lin K, Yang X, Garibaldi LR, Bourdony CJ, Dolan LM, Donaldson DL.
    Pediatr Res; 1995 Jun; 37(6):820-4. PubMed ID: 7651769
    [Abstract] [Full Text] [Related]

  • 20. Male pseudohermaphroditism caused by nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) deficiency.
    Heinrich UE, Bettendorf M, Vecsei P.
    J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):83-5. PubMed ID: 8481355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.